BOSTON SCIENTIFIC CORP — Director's Dealing 2024

Jan 2, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2024-01-01

Reporting Person: Sorenson John Bradley (EVP, Global Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-01-01	Common Stock	M	7848.0000	$0.0000	Acquired	44537.0000	Direct
2024-01-01	Common Stock	F	3729.0000	$57.8100	Disposed	40808.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-01-01	Performance Share Units	$	M	7848.0000	Disposed	2023-12-31	Common Stock (7848.0000)	Direct

Footnotes

F1: On February 17, 2021, the reporting person was awarded a target number of performance share units under the Company's 2021 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2021 adjusted free cash flow measured against its 2021 financial plan over the one-year performance period ending December 31, 2021 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 22, 2022, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon completion of the individual service period that ended on December 31, 2023.

F2: Each performance shares unit represents the Company's commitment to issue one share of Boston Scientific common stock.